Jay L. Dinerman
Johns Hopkins University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jay L. Dinerman.
Neuropharmacology | 1994
Jay L. Dinerman; Joseph P. Steiner; Ted M. Dawson; Valina L. Dawson; Solomon H. Snyder
We have examined the regulation of neuronal nitric oxide synthase (NOS) by phosphorylation with cyclic-GMP (PKG) and cyclic-AMP-dependent (PKA) protein kinases. In vitro phosphorylation studies indicate that both PKG and PKA phosphorylate NOS on a single site. Phosphoamino-acid analysis and peptide mapping demonstrate that phosphorylation by either cyclic-nucleotide kinase occurs on a similar serine residue. Phosphorylation of purified NOS by either PKG or PKA diminishes catalytic activity. Stimulation by 8-Br-cGMP of HEK-293 cells stably transfected with the cDNA for neuronal NOS (293.NOS cells) results in phosphorylation of immunoprecipitated NOS. Incubation of 293-NOS cells with 8-bromo-cGMP or dibutyryl-cAMP reduces nitrite release in response to stimulation with calcium ionophore A23187. Phosphorylation-induced decreases in NOS activity may counterbalance and modulate NOS activating signals.
Journal of Clinical Investigation | 1998
Pitayadet Jumrussirikul; Jay L. Dinerman; Ted M. Dawson; Valina L. Dawson; Ulf Ekelund; Dimitrios Georgakopoulos; Lawrence P. Schramm; Hugh Calkins; Solomon H. Snyder; Joshua M. Hare; Ronald D. Berger
Nitric oxide (NO) synthesized within mammalian sinoatrial cells has been shown to participate in cholinergic control of heart rate (HR). However, it is not known whether NO synthesized within neurons plays a role in HR regulation. HR dynamics were measured in 24 wild-type (WT) mice and 24 mice in which the gene for neuronal NO synthase (nNOS) was absent (nNOS-/- mice). Mean HR and HR variability were compared in subsets of these animals at baseline, after parasympathetic blockade with atropine (0.5 mg/kg i.p.), after beta-adrenergic blockade with propranolol (1 mg/kg i.p.), and after combined autonomic blockade. Other animals underwent pressor challenge with phenylephrine (3 mg/kg i.p.) after beta-adrenergic blockade to test for a baroreflex-mediated cardioinhibitory response. The latter experiments were then repeated after inactivation of inhibitory G proteins with pertussis toxin (PTX) (30 microgram/kg i.p.). At baseline, nNOS-/- mice had higher mean HR (711+/-8 vs. 650+/-8 bpm, P = 0.0004) and lower HR variance (424+/-70 vs. 1,112+/-174 bpm2, P = 0.001) compared with WT mice. In nNOS-/- mice, atropine administration led to a much smaller change in mean HR (-2+/-9 vs. 49+/-5 bpm, P = 0.0008) and in HR variance (64+/-24 vs. -903+/-295 bpm2, P = 0.02) than in WT mice. In contrast, propranolol administration and combined autonomic blockade led to similar changes in mean HR between the two groups. After beta-adrenergic blockade, phenylephrine injection elicited a fall in mean HR and rise in HR variance in WT mice that was partially attenuated after treatment with PTX. The response to pressor challenge in nNOS-/- mice before PTX administration was similar to that in WT mice. However, PTX-treated nNOS-/- mice had a dramatically attenuated response to phenylephrine. These findings suggest that the absence of nNOS activity leads to reduced baseline parasympathetic tone, but does not prevent baroreflex-mediated cardioinhibition unless inhibitory G proteins are also inactivated. Thus, neuronally derived NO and cardiac inhibitory G protein activity serve as parallel pathways to mediate autonomic slowing of heart rate in the mouse.
Pacing and Clinical Electrophysiology | 1997
Lawrence Rosenthal; Thomas J. Beck; Jerry R. Williams; Mahadevappa Mahesh; Michael G. Herman; Jay L. Dinerman; Huch Calkins; John H. Lawrence
Radiation exposure during fluoroscopic imaging poses potential risks to patients and physicians, especially during protracted cardiovascular or radiological interventional procedures. We describe a woman with refractory paroxysmal supraventricular tachycardia who underwent radiofrequency catheter ablation of the slow pathway involved in atrioventricular nodal reentrant tachycardia. The patient subsequently returned 4 weeks later with acute radiation dermatitis that was retrospectively attributed to a malfunction in the fluoroscopy unit that lacked a maximum current output cut‐off switch. Using dose reconstruction studies and her estimated biological response, we determined that she received between 15 and 20 Gy (1 Gy = 100 rods) to the skin on her back during the procedure. The exposure will result in an increase in her lifelong risk of skin and lung cancer. This article underscores the potential for radiation‐induced injury during lengthy therapeutic procedures using x‐ray equipment.
Journal of Cardiovascular Electrophysiology | 2000
Eric Taylor; Ronald D. Berger; John D. Hummel; Jay L. Dinerman; Bruce Kenknight; Amelia M. Arria; Gordon F. Tomaselli; Hugh Calkins
Initiation of Sustained Ventricular Arrhythmias. Introduction: The purpose of this study was to analyze the pattern of initiation of sustained ventricular arrhythmias in patients with varying types of underlying structural heart disease.
Journal of Cardiovascular Electrophysiology | 1996
Jay L. Dinerman; Ronald D. Berger; Hugh Calkins
Temperature Monitoring During RF Ablation. Thermal injury is the primary mechanism of lesion formation during radiofrequency catheter ablation procedures. Irreversible tissue injury requires heating to approximately 50°C. Temperatures above 100°C result in coagulum formation. Because of this importance of temperature during radiofrequency catheter ablation procedures, temperature monitoring has been proposed as a tool to facilitate catheter ablation procedures. The results of recent clinical studies demonstrate that electrode temperatures do not differ at successful and failed ablation sites, electrode temperature does not predict or eliminate the possibility of arrhythmia recurrence, and closed‐loop temperature control decreases but does not eliminate the development of coagulum nor guarantees that target temperatures will be achieved. These observations are due in large part to the important distinctions between electrode temperature, the temperature at the electrode‐tissue interface, and the temperature at the ablation target. Nonetheless, temperature monitoring and temperature control are valuable tools during radiofrequency ablation procedures as they provide important information regarding the adequacy of tissue heating, minimize the development of coagulum, and maximize lesion size.
American Journal of Cardiology | 1997
Jay L. Dinerman; Ronald D. Berger; Mark C.P. Haigney; John H. Lawrence; Gordon F. Tomaselli; Hugh Calkins
We sought to evaluate the electrophysiologic substrate for ventricular arrhythmias and sudden cardiac death in patients with idiopathic dilated cardiomyopathy. When compared with controls, patients with cardiomyopathy had prolonged activation times, increased dispersion of activation and recovery, and prolonged duration of monophasic action potential recordings at 70%, but not at 90%, of repolarization.
Annals of Internal Medicine | 1994
Charles J. Lowenstein; Jay L. Dinerman; Solomon H. Snyder
Proceedings of the National Academy of Sciences of the United States of America | 1994
Jay L. Dinerman; Ted M. Dawson; Michael J. Schell; Adele M. Snowman; Solomon H. Snyder
Proceedings of the National Academy of Sciences of the United States of America | 1993
Ted M. Dawson; Joseph P. Steiner; Valina L. Dawson; Jay L. Dinerman; George R. Uhl; Solomon H. Snyder
Science | 1994
Thomas J. O'Dell; Paul L. Huang; Ted M. Dawson; Jay L. Dinerman; Solomon H. Snyder; Eric R. Kandel; Mark C. Fishman